Skip to main content
  • New Chikungunya vaccine is under trial

    The International Vaccine Institute announced the first participant received Bharat Biotech International Ltd’s (BBIL) Chikungunya vaccine candidate (BBV87) in a Phase II/III clinical trial in Costa Rica, marking the start of a multi-country study led by IVI in partnership with BBIL and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the Ind-CEPI mission of the Department of Biotechnology, India.

  • Researchers reverse age-related memory loss in mice

    In a study published in Molecular Psychiatry, the team show that changes in the extracellular matrix of the brain –  scaffolding around nerve cells – lead to loss of memory with ageing, but that it is possible to reverse these using genetic treatments.

  • Millions of diseases can be prevented by reducing sugar of packaged foods and beverages

    Cutting 20% of sugar from packaged foods and 40% from beverages could prevent 2.48 million cardiovascular disease events (such as strokes, heart attacks, cardiac arrests), 490,000 cardiovascular deaths, and 750,000 diabetes cases in the U.S. over the lifetime of the adult population, reports a study published in Circulation.

  • Prediction of organ transplant rejection using artificial blood vessels

    Organ transplantation involves the transplantation of organs from donors as a means to treat disease or injury, but there is a shortage of organs available for donation compared to the demand for organ transplantation. Research involving the transplantation of animal organs (xenotransplantation) is ongoing, considering its potential to overcome these challenges.

  • Is it possible to personalise sudden cardiac death prevention after myocardial infarction?

    The largest analysis aimed at more accurately predicting the risk of sudden cardiac death after myocardial infarction is presented in late breaking results from the PROFID consortium at ESC Congress 2021.

  • Indian Scientist Partners with BRICS Group to Setup Network of Genomic Surveillance and Study the Overlap of SARS-CoV-2 with tuberculosis

    Department of Biotechnology, Ministry of Science and Technology, Government of India in collaboration with BRICS countries is implementing SARS-CoV-2 NGS-BRICS consortium and multi centric programme to study the impact of severe COVID-19 conditions on TB patients.

  • Novel AI Blood Testing Technology Can ID Lung Cancers with High Accuracy

    DELFI blood test identifies lung cancer using artificial intelligence to detect unique patterns in the fragmentation of DNA shed from cancer cells compared to normal profiles. Credit: Carolyn Hruban

    A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly 800 individuals with and without cancer.

  • Researchers develop novel strategy for tuberculosis vaccine

    Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis.

  • Zycov-D, needle free COVID vaccine in the world is approved in India

    Zydus Cadila announced that the company has received the Emergency Use Authorization from the Drug Controller General of India (DCGI) for ZyCoV-D the worlds first Plasmid DNA Vaccine for COVID-19. ZyCoV-D is a three dose vaccine which will be administered first on day zero, day 28th and then on the 56th day. With this approval, India now has its first COVID-19 vaccine for the adolescents in the 12-18 age group, besides the adult population.

  • Microbes turn back the clock as UCC research discovers their potential to reverse aging in the brain

    Research from APC Microbiome Ireland (APC) SFI Research Centre at University College Cork (UCC) published today in the leading international scientific journal Nature Aging introduces a novel approach to reverse aspects of aging-related deterioration in the brain and cognitive function via the microbes in the gut.

Subscribe to Research News

Search this website